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introduction
Myocardial ischemia-reperfusion (IR) injury occurs 
frequently in a variety of clinical settings.[1,2] Remote 
ischemic preconditioning (RIPC) induced by transient limb 
ischemia has been shown to be a feasible and noninvasive 
approach for cardioprotection and offers both early-phase 
and late-phase protection.[3-6] The early-phase protection 
lasted for up to 3 h after RIPC, whereas the late-phase 
protection started after 24 h and lasted for up to 72–96 h, or 
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Background: Plasma transfusion is a common clinical practice. Remote ischemic preconditioning (RIPC) protects organs against 
ischemia-reperfusion (IR) injury. Whether preconditioned plasma (PP), collected at late phase after RIPC, could protect organs against IR 
injury in vivo is unknown. This study explored whether transfusion of PP could reduce myocardial infarct size (IS) after IR in rat in vivo.
Methods: Eighty Lewis rats were randomized to eight groups (n = 10 for each group). Two groups of plasma donor rats donated plasma 
at 48 h after transient limb ischemia (PP) or control protocol (nonpreconditioned plasma [NPP]). Six groups of recipient rats received 
normal saline (NS; NS-IR 1, and NS-IR 24 groups), NPP (NPP-IR 1 and NPP-IR 24 groups), or PP (PP-IR 1 and PP-IR 24 groups) at one 
or 24 h before myocardial IR. Myocardial IR consisted of 30-min left anterior descending (LAD) coronary artery occlusion and 180-min 
reperfusion. The area at risk (AAR) and infarct area were determined by double-staining with Evans blue and triphenyltetrazolium chloride. 
IS was calculated by infarct area divided by AAR. This was a 3 × 2 factorial design study, and factorial analysis was used to evaluate the 
data. If an interaction between the fluid and transfusion time existed, one‑way analysis of variance with Bonferroni correction for multiple 
comparisons was used to analyze the single effects of fluid type when the transfusion time was fixed.
Results: IS in the NPP-IR 1 and PP-IR 1 groups was smaller than in the NS-IR 1 group (F = 6.838, P = 0.005; NPP-IR 1: 57 ± 8% vs. 
NS-IR1: 68 ± 6%, t = 2.843, P = 0.020; PP-IR 1: 56 ± 8% vs. NS-IR 1: 68 ± 6%, t = 3.102, P = 0.009), but no significant difference was 
detected between the NPP-IR 1 and PP-IR 1 groups (57 ± 8% vs. 56 ± 8%, t = 0.069, P = 1.000). IS in the NPP-IR 24 and PP-IR 24 groups 
was smaller than in the NS-IR 24 group (F = 24.796, P < 0.001; NPP-IR 24: 56% ± 7% vs. NS-IR 24: 68 ± 7%, t = 3.102, P = 0.026; 
PP-IR 24: 40 ± 9% vs. NS-IR 24: 68 ± 7%, t = 7.237, P < 0.001); IS in the PP-IR 24 group was smaller than in the NPP-IR 24 group (40 
± 9% vs. 56 ± 7%, t = 4.135, P = 0.002).
Conclusion: Transfusion of PP collected at late phase after remote ischemic preconditioning could reduce IS, suggesting that late-phase 
cardioprotection was transferable in vivo.
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sometimes for weeks.[6] However, the mechanism underlying 
the protective effects of RIPC is unclear.
Recently, some studies showed that humoral factors were 
responsible for the infarct-sparing effects.[7-11] Identifying 
these protective factors has been without success as humoral 
components comprise a reservoir of cardioprotective 
factors.[12,13] Current data suggest that preconditioned 
plasma (PP) (obtained from individuals after RIPC) contains 
cardioprotective factors released after RIPC, and that 
transfer of protection induced by RIPC between individuals 
through plasma transfusion may be possible.[7,8] Previous 
studies[7,14] focused on whether early-phase protection could 
be transferred, but the mechanism involved in the late phase 
of protection suggested that new proteins may be produced 
and that protective factors may be more persistent than those 
in the early-phase; therefore, transfer of late-phase protection 
may be more clinically applicable.[15]
We hypothesized that PP might be a reservoir of 
cardioprotective factors and that late-phase protection 
induced by RIPC could be transferred through plasma 
transfusion between individuals in vivo. Therefore, this study 
aimed to investigate whether transfusion of plasma collected 
at the late-phase of protection could reduce infarct size (IS) 
in an in vivo IR rat model.
methods
Ethics
All animal protocols were approved by the Institutional 
Animal Care and Use Committee of Sun Yat-sen 
University (No. LAEC-2012-0602).
Animals and grouping
Eighty 10- to 12-week-old, average weight 260 g 
(mean: 260 ± 9 g) male Lewis rats (Vital River Company, Beijing, 
China) were completely randomized to eight groups (n = 10 for 
each group) according to a computer-generated randomization 
list, including two groups of plasma donor rats (PD groups) 
and six groups of myocardial IR rats (study groups). The PD 
groups were divided into two subgroups according to whether 
transient limb ischemia was induced (PDLI) or not (PD 
control [PDC]). Depending on the type of fluid transfused 
and the transfusion time before ischemia, the study groups 
were divided into six subgroups: received normal saline (NS) 
1 h before ischemia, NS-IR 1 group; received NS 24 h before 
ischemia, NS-IR 24 group; received nonpreconditioned 
plasma (NPP) 1 h before ischemia, NPP-IR 1 group; received 
NPP 24 h before ischemia, NPP-IR 24 group; received PP 1 h 
before ischemia, PP-IR 1 group; and received PP 24 h before 
ischemia, PP-IR 24 group.
Transient limb ischemia
The rats of PDLI group were anesthetized with intraperitoneal 
pentobarbital (50 mg/kg) and then underwent transient limb 
ischemia. Transient limb ischemia was induced by tying 
elastic rubber bands around both proximal hind limbs for 
5 min, followed by 5 min of reperfusion by releasing the 
noninvasive ligature. Management of the rats in PDC group 
was identical to that in PDLI group, except that the elastic 
bands placed on both hind limbs were not tied.
Plasma preparation and transfusion
Forty-eight hours after completing the ischemia or control 
protocol, blood was drawn from the PD rats. PP was obtained 
from the rats undergoing transient limb ischemia, while 
NPP was obtained from the rats without transient limb 
ischemia. According to the grouping, 2 ml of NS, or NPP 
or PP was immediately transfused into the assigned IR rats 
through the caudal vein at a rate of 1 ml/min, either one or 
24 h before inducing IR. The detailed protocols of transient 
limb ischemia, plasma preparation, and transfusion were as 
described in our previous paper.[9]
Myocardial ischemia and reperfusion
A myocardial IR model was established as previously 
described.[9] Briefly, IR rats were anesthetized with 
intraperitoneal pentobarbital (60 mg/kg), intubated, and 
ventilated (Harvard Rodent Ventilator, Holliston, USA) with 
room air, at a tidal volume of 8–10 ml/kg and a respiratory rate 
of 70–80/min. The right jugular vein was cannulated for fluid 
administration, and the right carotid artery was cannulated for 
blood pressure monitoring (Harvard Transducer, Holliston, 
USA). The rats were monitored closely for oxygenation 
by arterial blood gas analysis. The electrocardiogram was 
monitored continuously by a BIOPAC system (BIOPAC, 
Goleta, USA) throughout the experiment. The rectal 
temperature was maintained at 36.8–37.2°C by placing the 
rat on a heating pad (Nuanfeng Heating Element Company, 
Suzhou, China) and carefully adjusting the levels of heating. 
Left thoracotomy was performed between the third and fourth 
ribs, and the LAD coronary artery was identified and ligated 
with 7-0 polypropylene suture tunneled under the LAD. 
A slipknot was tied over a section of cotton thread placed 
directly over the vessel to create the occlusion. Occlusion 
was deemed successful when the myocardium supplied by the 
vessel turned pale. After 30 min of ischemia, the slipknot was 
released by gently pulling the slipknot suture in the opposite 
direction, and the cotton thread was then pulled out. At this 
time, reperfusion began for 180 min.
Infarct size analysis
Ischemic area (IA) was defined as the percentage of area 
at risk (AAR) in the entire left ventricle (LV), and IS was 
defined as the percentage of IA in the AAR. AAR and IA 
were determined by double-staining with Evans blue and 
triphenyltetrazolium chloride (TTC). After 180 min of 
reperfusion, the polypropylene suture tunneled under the LAD 
was retied, and 4 ml of 2% Evans blue (Sigma, St. Louis, USA) 
was given intravenously to distinguish the AAR (unstained 
portion of myocardium) from the area not at risk (Evans 
blue-stained portion of myocardium). The heart was excised 
under pentobarbital anesthesia, and the rat was sacrificed 
after the heart excision under anesthesia. The right ventricle 
was removed on ice. The LV including the septum was 
held at −20°C for 30 min and then cut into slices of about 
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2 mm from apex to base. The slices were incubated in 1% 
TTC (Sigma, St. Louis, USA) solution at 37°C for 15 min to 
distinguish dead tissue (pale color) from viable tissue (Evans 
blue-stained portion of myocardium appeared to be slightly 
blue-brown, and Evans blue-unstained portion of myocardium 
appeared to be strongly red). The slices were then fixed in 
10% formalin for 20 min. The stained slices were placed on a 
glass slide and covered by another glass slide. Two-millimeter 
shims at the four corners held the glass away from the bottom 
sheet. The slices were then compressed to 2 mm by pressing 
the upper glass down against the shims using spring clamps. 
Images of both sides of each slice were taken with a Leica 
M205 FA microscope (Leica Microsystems, Solms, Germany) 
using a Leica DFC 420 camera, and AAR and IA were then 
determined via planimetry using Image J 1.46r (National 
Institutes of Health, Bethesda, USA). IS and IA were 
calculated according to the above-mentioned method.
Statistical analysis
Based on previous literature,[7,16] we preliminarily set the sample 
size as n = 10 in each group and then determined the mean and 
standard deviation (SD) in each group (n = 8, because 2 rats 
died in each group). The sample size was then calculated based 
on the mean, SD, and the set statistical power ([1− β] = 0.8, 
α = 0.05), resulting in a required sample size of n = 6 in each 
group. Our sample size satisfied the requirement.
The data were analyzed with SPSS 16.0 (SPSS, Inc., 
Chicago, IL, USA). All values were expressed as mean ± SD. 
This study had a 3 × 2 factorial design. Factorial analysis was 
used to test the main effects of fluid type and transfusion time 
on IS and to determine whether an interaction between the 
fluid and transfusion time existed. If an interaction existed, 
one-way analysis of variance with Bonferroni correction for 
multiple comparisons was used to analyze the single effects 
of fluid type when the transfusion time was fixed. Differences 
were regarded as statistically significant when P < 0.05.
results
Rats excluded from study
There was no dropout in the PD groups. No study rats had 
heart failure after 2 ml of plasma transfusion. Two rats died 
in each study group during the IR procedure, so the sample 
size was 8 in each study group [Table 1].
Myocardial ischemic area
IA (AAR/LV) did not differ significantly among the 
NS-IR 1, NPP-IR 1, and PP-IR 1 groups (NS-IR 1: 37 ± 
10%, NPP-IR 1: 35 ± 11%, PP-IR 1: 35 ± 11%; F = 0.196, 
P = 0.824) or among the NS-IR 24, NPP-IR 24, and PP-IR 24 
groups (NS-IR 24: 39 ± 10%, NPP-IR 24 35 ± 11%, PP-IR 
24 35 ± 7%; F = 0.337, P = 0.718) [Figure 1].
Effect of preconditioned plasma on myocardial infarct 
size
Transfusion 1 h before ischemia
IS in the NPP‑IR 1 or PP‑IR 1 groups was significantly 
reduced compared to that in the NS-IR 1 group (F = 6.838, 
P = 0.005; NPP-IR 1: 57 ± 8% vs. NS-IR1: 68 ± 6%, 
t = 2.843, P = 0.020; PP-IR 1: 56 ± 8% vs. NS-IR 1: 68 ± 6%, 
t = 3.102, P = 0.009). However, IS did not differ between 
the NPP-IR1 and PP-IR1 groups (57 ± 8% vs. 56 ± 8%, 
t = 0.069, P = 1.000) [Figures 2 and 3].
Transfusion 24 h before ischemia
IS in the NPP‑IR 24 and PP‑IR 24 groups was significantly 
reduced compared to that in the NS-IR 24 group (F = 24.796, 
P < 0.001; NPP-IR24: 56 ± 7% vs. NS-IR24: 68 ± 7%, 
t = 3.102, P = 0.026; PP-IR24: 40 ± 9% vs. NS-IR24: 68 ± 7%, 
t = 7.237, P < 0.001). Compared to the IS in the NS-IR24 
group, the IS in the NPP-IR24 group was reduced by 
17% and that in the PP-IR24 group was reduced by 40%. 
Moreover, IS in the PP-IR 24 group was reduced by 28% 
compared to that in the NPP-IR24 group (40 ± 9% vs. 56 ± 
7%, t = 4.135, P = 0.002) [Figures 2 and 3].
discussion
Our study found that transfusion of PP collected at 
the late-phase of protection into recipients 24 h before 
Figure 1: Myocardial IA in different groups (n = 8 for each 
group). IA (AAR/LV) did not differ significantly among the NS‑IR 
1, NPP‑IR 1, and PP‑IR 1 groups or the NS‑IR 24, NPP‑IR 24, and 
PP‑IR 24 groups (P > 0.05). Bars represent the standard deviation 
in each group. IA: Ischemic area; AAR: Area at risk; LV: Left ventricle; 
IR: Ischemia‑reper fusion; NPP: Nonpreconditioned plasma; 
PP: Preconditioned plasma; NS: Natural saline.
Table 1: The causes of death in each study group of 
rat (n = 10 per group)
Group Massive bleeding, n Obstruction of trachea, n
NS-IR 1 1 1
NS-IR 24 2 0
NPP-IR 1 2 0
NPP-IR 24 2 0
PP-IR 1 1 1
PP-IR 24 2 0
IR: Ischemia-reperfusion; NPP: Nonpreconditioned plasma; 
PP: Preconditioned plasma; NS: Natural saline; IR 1: 1 h before IR; IR 
24: 24 h before IR.
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myocardial IR could reduce IS. However, PP did not 
significantly reduce IS when transfused 1 h before IR, 
compared to the result with NPP.
Myocardial IS is recognized as a determining factor in 
myocardial infarction prognosis.[17] Previous studies[18,19] on 
animals and patients showed that the lager the IS, the more 
severe the LV dysfunction. Reducing IS is a therapeutic 
goal for myocardial infarction. The present study showed 
that transfusion of PP 24 h before ischemia could reduce the 
IS by about 40%, compared to the result with transfusion 
of NS, and by nearly 30%, compared to that with NPP. IS 
reduction in our study was smaller than that reported in 
previous studies, in which IPC or RIPC could reduce IS by 
at least 50%.[20,21] This difference may be due to different 
study regimens. The total blood volume of the rats in this 
study was about 16 ml.[22] The 2 ml of transfused plasma 
only accounted for about 13% of total blood volume. This 
suggests that a small amount of PP transfusion can achieve 
a protective effect.
In previous in vitro studies, the transfer of preconditioned 
humoral fluid (coronary effluent, whole blood, or plasma) 
occurred just before ischemia; a larger amount of humoral 
fluid was transferred, and the transferring process took a 
long time.[23,24] In Dickson’s study,[24] donor preconditioned 
hearts underwent repeated brief ischemia on a Langendorff 
apparatus, and coronary effluent was collected during 
the preconditioning period; then, recipient hearts were 
perfused with the effluent for 30 min before being subjected 
to a long-term IR episode. In another study[24] by the 
same research group, 1 min prior and after each of 5 IPC 
episodes, 5 ml of whole blood was exchanged between 
the preconditioned rabbit and the matched rabbit, and all 
rabbits underwent blood exchange 10 times. In Shimizu’s 
study,[7] plasma dialysate was obtained at the end of the 
RIPC protocol from preconditioned rabbits or preconditioned 
human volunteers and then added to the buffer to perfuse 
rabbit hearts for 35 min before subjecting the heart to a 
long period of IR. These studies have important scientific 
implications: they confirmed that the protective effects of 
IPC could be transferred by humoral fluid. However, all the 
procedures seemed very complicated. Our study showed that 
transfusing a small volume of PP in a relatively short period 
can limit IS to a large extent.
Previous studies[7,14] focused on whether protection in the 
early phase could be transferred. In the present study, we 
selected 48 h after transient limb ischemia as the time point 
of plasma collection, which was clearly in the late phase of 
protection, to explore whether protection in the late phase 
could be transferred via plasma. We also explored the transfer 
of protective effects of RIPC based on when the plasma was 
transfused. Our results showed that PP transfused at 24 h 
but not 1 h before ischemia could reduce IS. We speculated 
that the PP may contain cardioprotective substances acting 
Figure 2: Myocardial infarct size in different groups (n = 8 
for each group). Bars represent the standard deviation in each 
group. *Compared to NS‑IR1, P < 0.05, †Compared to NS‑IR24, 
P < 0.05, ‡Compared to NPP‑IR 24, P < 0.05. IA: Ischemic area; 
AAR: Area at risk; IR: Ischemia‑reperfusion; NPP: Nonpreconditioned 
plasma; PP: Preconditioned plasma; NS: Natural saline.
Figure 3: Representative images of Evans blue and triphenyltetrazolium chloride double‑stained myocardial slices. Each line shows the representative 
images from one left ventricle in each study group. The Evans blue positive‑staining region (blue‑brown color) is the nonischemic region. The 
pale‑appearing triphenyltetrazolium chloride negative‑staining region is the infarct area. The Evans blue negative‑staining region, including the 
strongly red‑appearing triphenyltetrazolium chloride positive‑staining region and the infarct area, are the areas at risk. IR: Ischemia‑reperfusion; 
NPP: Nonpreconditioned plasma; PP: Preconditioned plasma; NS: Natural saline; IR 1: 1 h before IR; IR 24: 24 h before IR.
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as an initiator, and the initiator may need time to activate 
the protective signaling system. However, further studies 
are needed to verify this hypothesis.
Interestingly, this study also showed that transfusion of NPP 
could reduce IS, compared to the result with transfusion 
of NS. The mechanism may involve that the plasma of 
donor rats could maintain blood volume more effectively 
than NS and contain the possible residual pentobarbital 
from anesthesia administration. Moreover, whether the 
stretch-activated mechanism was involved in the protection 
induced by NPP transfusion remains to be further explored.
This study was started in 2012 but was published later than 
a similar study by Skyschally et al.[14] However, our study 
examined the protective effect of PP on individuals of the 
same species and focused on the late phase of protection; 
in contrast, Skyschally’s study explored the effect between 
species and focused on the early phase of protection.
This study examined the myocardial protective effect of 
PP transfusion at 1 or 24 h before ischemia, but the effect 
of transfusion at more time points before ischemia needs 
further investigation. Furthermore, whether there is a 
dose-dependent effect and the mechanism underlying the 
transfer of the protective effect should be studied in the 
future.
In conclusion, this study reported the use of an in vivo 
model to show that transfusion of late-phase PP into IR 
rats 24 h before ischemia could reduce IS. These findings 
suggest that cardioprotection by RIPC is transferable via 
plasma in vivo.
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